160 related articles for article (PubMed ID: 23387971)
1. Dendrimer-curcumin conjugate: a water soluble and effective cytotoxic agent against breast cancer cell lines.
Debnath S; Saloum D; Dolai S; Sun C; Averick S; Raja K; Fata JE
Anticancer Agents Med Chem; 2013 Dec; 13(10):1531-9. PubMed ID: 23387971
[TBL] [Abstract][Full Text] [Related]
2. Evaluating the Anti-cancer Efficacy of a Synthetic Curcumin Analog on Human Melanoma Cells and Its Interaction with Standard Chemotherapeutics.
Parashar K; Sood S; Mehaidli A; Curran C; Vegh C; Nguyen C; Pignanelli C; Wu J; Liang G; Wang Y; Pandey S
Molecules; 2019 Jul; 24(13):. PubMed ID: 31284561
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and biological evaluation of glucosyl curcuminoids.
Bhaskar Rao A; Prasad E; Deepthi SS; Ansari IA
Arch Pharm (Weinheim); 2014 Nov; 347(11):834-9. PubMed ID: 25142301
[TBL] [Abstract][Full Text] [Related]
4. Antitumor agents. Part 214: synthesis and evaluation of curcumin analogues as cytotoxic agents.
Ishida J; Ohtsu H; Tachibana Y; Nakanishi Y; Bastow KF; Nagai M; Wang HK; Itokawa H; Lee KH
Bioorg Med Chem; 2002 Nov; 10(11):3481-7. PubMed ID: 12213462
[TBL] [Abstract][Full Text] [Related]
5. A Novel Fluorescence-Labeled Curcumin Conjugate: Synthesis, Evaluation and Imaging on Human Cell Lines.
Sheikh S; Sturzu A; Kalbacher H; Nagele T; Weidenmaier C; Horger M; Schwentner C; Ernemann U; Heckl S
Curr Pharm Des; 2018; 24(16):1821-1826. PubMed ID: 29623828
[TBL] [Abstract][Full Text] [Related]
6. The Curcumin Analogue, MS13 (1,5-Bis(4-hydroxy-3- methoxyphenyl)-1,4-pentadiene-3-one), Inhibits Cell Proliferation and Induces Apoptosis in Primary and Metastatic Human Colon Cancer Cells.
Ismail NI; Othman I; Abas F; H Lajis N; Naidu R
Molecules; 2020 Aug; 25(17):. PubMed ID: 32825505
[TBL] [Abstract][Full Text] [Related]
7. Solubility enhancement and targeted delivery of a potent anticancer flavonoid analogue to cancer cells using ligand decorated dendrimer nano-architectures.
Luong D; Kesharwani P; Killinger BA; Moszczynska A; Sarkar FH; Padhye S; Rishi AK; Iyer AK
J Colloid Interface Sci; 2016 Dec; 484():33-43. PubMed ID: 27585998
[TBL] [Abstract][Full Text] [Related]
8. Preparation, Characterization and In Vitro Biological Evaluation of Novel Curcumin Derivatives as Cytotoxic and Apoptosis-Inducing Agents.
Arjomandi OK; Almasi S; Hosseinzadeh L; Kavoosi M; Adibi H
Anticancer Agents Med Chem; 2021; 21(10):1309-1322. PubMed ID: 33006540
[TBL] [Abstract][Full Text] [Related]
9. Characterization of CurcuEmulsomes: nanoformulation for enhanced solubility and delivery of curcumin.
Ucisik MH; Küpcü S; Schuster B; Sleytr UB
J Nanobiotechnology; 2013 Dec; 11():37. PubMed ID: 24314310
[TBL] [Abstract][Full Text] [Related]
10. Synthesis, characterization and anti-cancer activity of Pluronic F68-curcumin conjugate micelles.
Cai Y; Sun Z; Fang X; Fang X; Xiao F; Wang Y; Chen M
Drug Deliv; 2016 Sep; 23(7):2587-2595. PubMed ID: 26066393
[TBL] [Abstract][Full Text] [Related]
11. Synthesis and biological analysis of a new curcumin analogue for enhanced anti-tumor activity in HepG 2 cells.
Xiao J; Chu Y; Hu K; Wan J; Huang Y; Jiang C; Liang G; Li X
Oncol Rep; 2010 May; 23(5):1435-41. PubMed ID: 20372861
[TBL] [Abstract][Full Text] [Related]
12. Synthesis and biological evaluation of new symmetric curcumin derivatives.
Sribalan R; Kirubavathi M; Banuppriya G; Padmini V
Bioorg Med Chem Lett; 2015 Oct; 25(19):4282-6. PubMed ID: 26264500
[TBL] [Abstract][Full Text] [Related]
13. Cytotoxic, Genotoxic and Senolytic Potential of Native and Micellar Curcumin.
Beltzig L; Frumkina A; Schwarzenbach C; Kaina B
Nutrients; 2021 Jul; 13(7):. PubMed ID: 34371895
[TBL] [Abstract][Full Text] [Related]
14. Curcumin analogue 1,5-bis(4-hydroxy-3-((4-methylpiperazin-1-yl)methyl)phenyl)penta-1,4-dien-3-one mediates growth arrest and apoptosis by targeting the PI3K/AKT/mTOR and PKC-theta signaling pathways in human breast carcinoma cells.
Badr G; Gul HI; Yamali C; Mohamed AAM; Badr BM; Gul M; Abo Markeb A; Abo El-Maali N
Bioorg Chem; 2018 Aug; 78():46-57. PubMed ID: 29533214
[TBL] [Abstract][Full Text] [Related]
15. Curcumin inhibits cell proliferation and promotes apoptosis in human osteoclastoma cell through MMP-9, NF-κB and JNK signaling pathways.
Cao F; Liu T; Xu Y; Xu D; Feng S
Int J Clin Exp Pathol; 2015; 8(6):6037-45. PubMed ID: 26261481
[TBL] [Abstract][Full Text] [Related]
16. Antiproliferative effect of an analog of curcumin bis-1,7-(2-hydroxyphenyl)-hepta-1,6-diene-3,5-dione in human breast cancer cells.
Kumaravel M; Sankar P; Rukkumani R
Eur Rev Med Pharmacol Sci; 2012 Dec; 16(14):1900-7. PubMed ID: 23242714
[TBL] [Abstract][Full Text] [Related]
17. Codelivery of Hydrophobic and Hydrophilic Drugs by Graphene-Decorated Magnetic Dendrimers.
Pourjavadi A; Asgari S; Hosseini SH; Akhlaghi M
Langmuir; 2018 Dec; 34(50):15304-15318. PubMed ID: 30424605
[TBL] [Abstract][Full Text] [Related]
18. Curcumin-albumin conjugates as an effective anti-cancer agent with immunomodulatory properties.
Aravind SR; Krishnan LK
Int Immunopharmacol; 2016 May; 34():78-85. PubMed ID: 26927614
[TBL] [Abstract][Full Text] [Related]
19. Synthesis and characterization of new curcumin derivatives as potential chemotherapeutic and antioxidant agents.
Ciochina R; Savella C; Cote B; Chang D; Rao D
Drug Dev Res; 2014 Mar; 75(2):88-96. PubMed ID: 24648190
[TBL] [Abstract][Full Text] [Related]
20. Curcumin analogue GO-Y030 inhibits STAT3 activity and cell growth in breast and pancreatic carcinomas.
Hutzen B; Friedman L; Sobo M; Lin L; Cen L; De Angelis S; Yamakoshi H; Shibata H; Iwabuchi Y; Lin J
Int J Oncol; 2009 Oct; 35(4):867-72. PubMed ID: 19724924
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
